Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
Oct9 (human)

Overview
Oct9 Probable transcription factor which exert its primary action widely during early neural development and in a very limited set of neurons in the mature brain. Defects in POU3F4 are a cause of deafness X-linked type 2 (DFNX2). A mixed type of deafness characterized by both conductive hearing loss resulting from stapes (perilymphatic gusher) fixation and progressive sensorineural deafness. Belongs to the POU transcription factor family. Class- 3 subfamily. Note: This description may include information from UniProtKB.
Protein type: DNA binding protein
Cellular Component: nucleus
Molecular Function: AT DNA binding; double-stranded DNA binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; sensory perception of sound; regulation of transcription, DNA-dependent; forebrain neuron differentiation
Reference #:  P49335 (UniProtKB)
Alt. Names/Synonyms: Brain-4; Brain-specific homeobox/POU domain protein 4; Brn-4; BRN4; DFN3; DFNX2; Oct-9; Octamer-binding protein 9; Octamer-binding transcription factor 9; OTF-9; OTF9; PO3F4; POU class 3 homeobox 4; POU domain, class 3, transcription factor 4; POU3F4
Gene Symbols: POU3F4
Molecular weight: 39,427 Da
Basal Isoelectric point: 7.07  Predict pI for various phosphorylation states
Select Structure to View Below

Oct9

Protein Structure Not Found.


STRING  |  neXtProt  |  Protein Atlas  |  BioGPS  |  DISEASE  |  Scansite  |  Pfam  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 S265-p EADSSTGsPtsIDKI
0 1 T267-p DSSTGsPtsIDKIAA
0 1 S268-p SSTGsPtsIDKIAAQ
  mouse

 
S265-p EADSSTGsPTSIDKI
T267 DSSTGsPTSIDKIAA
S268 SSTGsPTSIDKIAAQ
  rat

 
S265 EADSSTGSPTSIDKI
T267 DSSTGSPTSIDKIAA
S268 SSTGSPTSIDKIAAQ
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.